Minerva Surgical, Inc.
UTRSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$888
P/E Ratio—
52W High$0.001
52W Low$0.00001
Minerva Surgical, Inc. (UTRS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · UTRS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $50.29M | $52.10M | $37.77M | $26.01M |
| Cost of Revenue | $23.05M | $21.58M | $18.65M | $14.21M |
| Gross Profit | $27.24M | $30.52M | $19.12M | $11.80M |
| Gross Margin %(computed) | 54.17% | 58.58% | 50.62% | 45.38% |
| Operating Expenses | ||||
| R&D Expenses | $5.44M | $5.29M | $3.32M | $0.94M |
| G&A Expenses | $14.37M | $22.18M | $8.21M | $8.38M |
| Total Operating Expenses | $58.14M | $59.67M | $34.51M | $31.44M |
| Operating Income | ($30.90M) | ($29.14M) | ($15.39M) | ($19.64M) |
| Operating Margin %(computed) | -61.44% | -55.94% | -40.75% | -75.49% |
| Interest Income | $0.09M | $0.01M | $0.08M | $0.14M |
| Interest Expense | $3.22M | $11.73M | $12.14M | $17.58M |
| Income Before Tax | ($34.10M) | ($21.45M) | ($18.39M) | ($52.05M) |
| Income Tax Expense | $0.01M | $0.01M | ($0.13M) | $0.00M |
| Net Income | ($34.11M) | ($21.46M) | ($18.26M) | ($52.05M) |
| Net Margin %(computed) | -67.83% | -41.20% | -48.36% | -200.08% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-23.68 | $-14.98 | $-17.91 | $-75.29 |
| Wtd Avg Shares | 1.44M | 1.43M | 1.02M | 0.93M |
| EBITDA | ($20.07M) | $0.89M | $0.82M | ($17.66M) |
| EBITDA Margin %(computed) | -39.91% | 1.71% | 2.17% | -67.88% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Minerva Surgical, Inc. data
About Minerva Surgical, Inc. (UTRS) Income Statement
Minerva Surgical, Inc. (UTRS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, UTRS reported revenue of $0.05B, gross profit of $0.03B (gross margin 54.17%), and net income of ($0.03B) — a net profit margin of -67.83%.
Frequently asked questions
UTRS · 4 questionsMinerva Surgical, Inc. (UTRS) reported revenue of $0.05B for 2022, down 3.5% year-over-year.
UTRS revenueUTRS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08